According To a Recent Report Published by Market Research Future, Titled “Biologics Market” By Type (Vaccines, Blood Products, Proteins, Gene Therapy, Other). The report provides a comprehensive analysis of current & future trends and emerging growth of Biologics Market globally. Worldwide forecast to 2023
Global Biologics Market – Overview
Biologics are the drug in the form of genetically engineered protein, derived from human gene. They are composed of proteins, nucleic acid or proteins substances. These drugs are derived from living organism including human, animals and microorganism. The major driving factor for the growth of the market are increasing incident of different chronic and acute diseases, introduction of new type of diseases, increasing demand for the better and biological therapy are the major driving factor for the growth of the market. Beside this continuous development in health care sector and advances in technology has provided fuel for the growth of the market. On the other hand long term approval time and high cost for environmental condition management may hamper the growth of the market. Global Biologic Market is expected to grow at a CAGR of 8.6% during Forecasted Period 2017-2023.
Avail Sample copy of the report @ https://www.marketresearchfuture.com/sample_request/1339 .
Unilife Corporation (US), Sanofi (France), Retractable Technologies Inc. (US), Smiths Medicals (UK), Becton, Dickinson & Company (Germany), Terumo Corporation (Japan), Pfizer Inc. (US), Roche Diagnostics (Switzerland), Amgen (US), GSK Biologicals (UK), Lundbeck (Denmark), Novartis AG (Switzerland), AstraZeneca (UK), Bayer AG (Germany), Genzyme (US), Merck KGaA (Germany), Samsung Biologics (South Korea), Celltrion (South Korea), Addgene (US), Johnson & Johnson Inc. (US), Eli Lilly & Company (US), Bristol-Myers Squibb (US), Biogen Inc. (US).
Global biologic market is segmented on the basis of type into vaccines, blood products, proteins, gene therapy and other. Vaccines are further sub segmented into inactivated, attenuated, toxoid and conjugate On the basis of application they are segmented into anemia, cancer, diabetes and other and on the basis of source they are segmented as human, animal, microorganism and other.
Global Biologics Market – Regional:
Geographically, North America has the largest biologic drug market. Due to increasing prevalence of diseases like Cancer and diabetes in North America is the major factor for the growth of the market. North America is followed by Europe in biologic market. Asia Pacific is the fastest growing region for biologic market. Biologic market growth of Asia Pacific is majorly driven by Japan, China and India. Beside this a huge population base in this region has provided a fuel for the growth of the market. Middle East and Africa has the least biologic market.
TOC of Biologics Market:
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL BIOLOGIC MARKET, BY TYPE
5.2 BLOOD PRODUCTS
5.4 GENE THERAPY
6. GLOBAL BIOLOGIC MARKET, BY APPLICATION
Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/1339 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312